Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome

Table 4

Abnormal organic function between group A and group B (number of patients).

Organic function	Indicator	Group A		Group B
		BTT	ATT	BTT	ATT
Liver functions	ALT	2	2	6	4
	AST	0	0	0	0
	GGT	1	0	0	0
Cardiac enzymes	LDH	2	2	4	3
	HBDH	4	3	4	3
	CK-MB	0	0	0	0
Renal functions	CRE	0	0	0	0
	BUN	0	0	0	0